+
Epigral Posts Q1FY26 Revenue of Rs 6.15 Bn; PAT Surges to Rs 1.60 Bn
ECONOMY & POLICY

Epigral Posts Q1FY26 Revenue of Rs 6.15 Bn; PAT Surges to Rs 1.60 Bn

Epigral, India’s integrated chemical major, reported revenue of Rs 6.15 billion for the quarter ended June 30, 2025, compared to Rs 6.54 billion in Q1FY25—a 6 per cent year-on-year decline, driven by softer volumes and lower realisations. Despite this, the company maintained a stable EBITDA margin of 27 per cent, supported by efficiency gains and an improved product mix. EBITDA stood at Rs 1.63 billion, a 7 per cent dip over the previous year.

Profit after tax (PAT) for the quarter stood at Rs 1.60 billion, benefiting from a Rs 810 million decrease in deferred tax liability. Excluding this, PAT was Rs 790 million versus Rs 860 million in the same quarter last year. Plant utilisation stood at 73 per cent during the quarter. The company’s return on capital employed (ROCE) improved to 24 per cent, up from 21 per cent a year ago, driven by better earnings, while Net Debt/EBITDA fell to 0.6x from 1.6x, reflecting stronger operating performance and deleveraging.

Revenue contribution from the Derivatives and Specialty Chemicals segment reached 50 per cent, and management expects this to rise further in coming quarters. Ongoing capex for CPVC and Epichlorohydrin capacity expansion remains on track in terms of budget and timeline. Additionally, the company plans to announce new investments for a remaining land parcel within its integrated complex.

Commenting on the performance, Maulik Patel, Chairman and Managing Director, said, “We expect H2FY26 to be stronger than H1FY26. Our focus on new chemistry aligned with import substitution will support high growth and strong ROCE. We continue to strengthen our integrated operations while pursuing scalable and profitable growth.”

Epigral, India’s integrated chemical major, reported revenue of Rs 6.15 billion for the quarter ended June 30, 2025, compared to Rs 6.54 billion in Q1FY25—a 6 per cent year-on-year decline, driven by softer volumes and lower realisations. Despite this, the company maintained a stable EBITDA margin of 27 per cent, supported by efficiency gains and an improved product mix. EBITDA stood at Rs 1.63 billion, a 7 per cent dip over the previous year.Profit after tax (PAT) for the quarter stood at Rs 1.60 billion, benefiting from a Rs 810 million decrease in deferred tax liability. Excluding this, PAT was Rs 790 million versus Rs 860 million in the same quarter last year. Plant utilisation stood at 73 per cent during the quarter. The company’s return on capital employed (ROCE) improved to 24 per cent, up from 21 per cent a year ago, driven by better earnings, while Net Debt/EBITDA fell to 0.6x from 1.6x, reflecting stronger operating performance and deleveraging.Revenue contribution from the Derivatives and Specialty Chemicals segment reached 50 per cent, and management expects this to rise further in coming quarters. Ongoing capex for CPVC and Epichlorohydrin capacity expansion remains on track in terms of budget and timeline. Additionally, the company plans to announce new investments for a remaining land parcel within its integrated complex.Commenting on the performance, Maulik Patel, Chairman and Managing Director, said, “We expect H2FY26 to be stronger than H1FY26. Our focus on new chemistry aligned with import substitution will support high growth and strong ROCE. We continue to strengthen our integrated operations while pursuing scalable and profitable growth.”

Next Story
Infrastructure Urban

CJ Logistics’ Global CEO visits India to align growth strategy

Jonathan Song, newly appointed CEO of the Global Business Division at South Korea-based CJ Logistics, concluded a strategic three-day visit to India from July 29 to 31, reinforcing the company’s long-term commitment to the market through its subsidiary, CJ Darcl Logistics Ltd. Mr Song held high-level discussions with the CJ Darcl leadership and key customers to understand India’s evolving logistics needs, identify synergy areas, and enhance business alignment. His visit highlighted the strategic significance of India in CJ Logistics’ global network, especially amid the country’s g..

Next Story
Real Estate

Max Towers secures five star rating in safety audit by British Council

Max Estates, a leading NCR-based real estate developer, has achieved a five star rating in its first attempt at the British Safety Council’s ‘Five Star Occupational Health and Safety’ Audit for Max Towers, its premium commercial office project in Noida. The grading reflects the organisation’s commitment to the continual improvement of its occupational health and safety systems. The comprehensive audit covered documentation, interviews with senior management and employees, stakeholder feedback, and rigorous sampling of on-ground activities. It assessed performance against best prac..

Next Story
Real Estate

India’s Tier 2 & 3 Cities: The Next Growth Frontier for Real Estate

Introduction India’s metropolitan cities have long dominated the real estate landscape, shaping both market trends and public discourse, but the narrative is shifting towards India’s tier 2 and 3 cities. Beyond the metro cities, Tier 2 and Tier 3 cities such as Indore, Ahmedabad, Chandigarh, Jaipur, Coimbatore, Lucknow, Bhubaneswar, Kochi, Surat, Guwahati, and many others are emerging as vibrant real estate hubs. This growth is driven by impetus from rapid urbanisation, logistics corridors like the Delhi Mumbai Industrial Corridor, IT/ITeS investment zones, emergence of global capabil..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?